265 related articles for article (PubMed ID: 26895104)
21. EZH2 is a negative prognostic factor and exhibits pro-oncogenic activity in glioblastoma.
Zhang J; Chen L; Han L; Shi Z; Zhang J; Pu P; Kang C
Cancer Lett; 2015 Jan; 356(2 Pt B):929-36. PubMed ID: 25444902
[TBL] [Abstract][Full Text] [Related]
22. SLC12A5 as a novel potential biomarker of glioblastoma multiforme.
Chen J; Wang H; Deng C; Fei M
Mol Biol Rep; 2023 May; 50(5):4285-4299. PubMed ID: 36917367
[TBL] [Abstract][Full Text] [Related]
23. Gene co-expression network construction and analysis for identification of genetic biomarkers associated with glioblastoma multiforme using topological findings.
Redekar SS; Varma SL; Bhattacharjee A
J Egypt Natl Canc Inst; 2023 Jul; 35(1):22. PubMed ID: 37482563
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme.
Martinez R; Schackert G; Esteller M
J Neurooncol; 2007 Apr; 82(2):133-9. PubMed ID: 17048097
[TBL] [Abstract][Full Text] [Related]
25. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
[TBL] [Abstract][Full Text] [Related]
26. Identification of key modules and hub genes in glioblastoma multiforme based on co-expression network analysis.
Li C; Pu B; Gu L; Zhang M; Shen H; Yuan Y; Liao L
FEBS Open Bio; 2021 Mar; 11(3):833-850. PubMed ID: 33423377
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
Vasaikar S; Tsipras G; Landázuri N; Costa H; Wilhelmi V; Scicluna P; Cui HL; Mohammad AA; Davoudi B; Shang M; Ananthaseshan S; Strååt K; Stragliotto G; Rahbar A; Wong KT; Tegner J; Yaiw KC; Söderberg-Naucler C
BMC Cancer; 2018 Feb; 18(1):154. PubMed ID: 29409474
[TBL] [Abstract][Full Text] [Related]
28. Regulatory Network of PD1 Signaling Is Associated with Prognosis in Glioblastoma Multiforme.
Lopes-Ramos CM; Belova T; Brunner TH; Ben Guebila M; Osorio D; Quackenbush J; Kuijjer ML
Cancer Res; 2021 Nov; 81(21):5401-5412. PubMed ID: 34493595
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM).
Grunda JM; Nabors LB; Palmer CA; Chhieng DC; Steg A; Mikkelsen T; Diasio RB; Zhang K; Allison D; Grizzle WE; Wang W; Gillespie GY; Johnson MR
J Neurooncol; 2006 Dec; 80(3):261-74. PubMed ID: 16773218
[TBL] [Abstract][Full Text] [Related]
30. Survival kinase genes present prognostic significance in glioblastoma.
Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
[TBL] [Abstract][Full Text] [Related]
31. Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival.
Michaelsen SR; Urup T; Olsen LR; Broholm H; Lassen U; Poulsen HS
J Neurooncol; 2018 May; 137(3):533-542. PubMed ID: 29305787
[TBL] [Abstract][Full Text] [Related]
32. Expression and clinical significance of CPS1 in glioblastoma multiforme.
Wu G; Yan Y; Zhou Y; Wang X; Wei J; Chen X; Lin W; Ou C; Zhou J; Xu Z
Curr Res Transl Med; 2019 Nov; 67(4):123-128. PubMed ID: 31492588
[TBL] [Abstract][Full Text] [Related]
33. Candidate Biomarkers and Molecular Mechanism Investigation for Glioblastoma Multiforme Utilizing WGCNA.
Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
Biomed Res Int; 2018; 2018():4246703. PubMed ID: 30356407
[TBL] [Abstract][Full Text] [Related]
34. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of PD-L1 expression in glioblastoma multiforme.
Heiland DH; Haaker G; Delev D; Mercas B; Masalha W; Heynckes S; Gäbelein A; Pfeifer D; Carro MS; Weyerbrock A; Prinz M; Schnell O
Oncotarget; 2017 Jun; 8(26):42214-42225. PubMed ID: 28178682
[TBL] [Abstract][Full Text] [Related]
36. Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patients.
Sana J; Radova L; Lakomy R; Kren L; Fadrus P; Smrcka M; Besse A; Nekvindova J; Hermanova M; Jancalek R; Svoboda M; Hajduch M; Slampa P; Vyzula R; Slaby O
Carcinogenesis; 2014 Dec; 35(12):2756-62. PubMed ID: 25322872
[TBL] [Abstract][Full Text] [Related]
37. Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma.
Jun F; Hong J; Liu Q; Guo Y; Liao Y; Huang J; Wen S; Shen L
Oncotarget; 2017 Feb; 8(9):14343-14358. PubMed ID: 27527869
[TBL] [Abstract][Full Text] [Related]
38. An update on the epigenetics of glioblastomas.
Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N
Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647
[TBL] [Abstract][Full Text] [Related]
39. Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.
Wang ZQ; Zhang MY; Deng ML; Weng NQ; Wang HY; Wu SX
PLoS One; 2017; 12(9):e0184969. PubMed ID: 28931080
[TBL] [Abstract][Full Text] [Related]
40. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
